Dai Qing, Xu Daiwang, Lim Keunpoong, Harvey Ronald G
The Ben May Department for Cancer Research, The University of Chicago, Chicago, Illinois 60637, USA.
J Org Chem. 2007 Jun 22;72(13):4856-63. doi: 10.1021/jo070518m. Epub 2007 May 27.
The synthesis of the C(8)-aryl adducts of adenine and guanine formed by reaction of the radical cation metabolites of carcinogenic polycyclic aromatic hydrocarbons (PAHs), such as benzo[a]pyrene (BP) and dibenzo[def,p]chrysene (DBC), with DNA is reported. The synthetic approach involves in the key step direct reaction of a PAH aldehyde with a di- or triamine precursor of a purine. The method is operationally simple, affords good yields of adducts, and is broad in its scope. The C(8)-aryl adducts of adenine and guanine derived from BP (6-BP-8-Ade and 6-BP-8-Gua) and DBC (10-DBC-8-Ade and 10-DBC-8-Gua) were synthesized in good yields by this method. Analogous C(8)-aryl adenine and guanine derivatives of other PAHs (anthracene, benz[a]anthracene, and chrysene) were also readily prepared via this approach. This method of synthesis is superior to the only method that is currently available. It entails direct reaction of short-lived PAH radical cations (generated electrochemically or chemically) with 2'-deoxyribonucleosides or the corresponding purine bases. It provides the adducts in low yields accompanied by complex mixtures of secondary products. An alternative synthesis that involves Pd-catalyzed Suzuki-Miyaura coupling of arylboronic acids with 8-bromopurine nucleosides was also investigated. Although the C(8)-purine adducts of PAHs, such as naphthalene, phenanthrene, pyrene, and chrysene, could be prepared by this method, analogous adducts of carcinogenic PAHs and other structurally related PAHs, e.g., anthracene, benz[a]anthracene, benzo[a]pyrene, and dibenzo[def,p]chrysene, could not be obtained. This difference was shown to be a consequence of the facility of competing hydrolytic deboronation of the corresponding arylboronic acids.
据报道,致癌多环芳烃(PAHs)如苯并[a]芘(BP)和二苯并[def,p]屈(DBC)的自由基阳离子代谢产物与DNA反应可形成腺嘌呤和鸟嘌呤的C(8)-芳基加合物。合成方法的关键步骤是PAH醛与嘌呤的二胺或三胺前体直接反应。该方法操作简单,加合物产率高,适用范围广。通过该方法以良好的产率合成了源自BP的腺嘌呤和鸟嘌呤的C(8)-芳基加合物(6-BP-8-Ade和6-BP-8-Gua)以及DBC的(10-DBC-8-Ade和10-DBC-8-Gua)。其他PAHs(蒽、苯并[a]蒽和 Chrysene)的类似C(8)-芳基腺嘌呤和鸟嘌呤衍生物也可通过该方法轻松制备出来。这种合成方法优于目前唯一可用的方法。后者需要短寿命的PAH自由基阳离子(通过电化学或化学方法产生)与2'-脱氧核糖核苷或相应的嘌呤碱直接反应。它产生的加合物产率低,还伴有复杂的副产物混合物。还研究了一种替代合成方法,该方法涉及钯催化的芳基硼酸与8-溴嘌呤核苷的铃木-宫浦偶联反应。尽管通过该方法可以制备PAHs如萘、菲、芘和 Chrysene的C(8)-嘌呤加合物,但无法获得致癌PAHs和其他结构相关PAHs(例如蒽、苯并[a]蒽、苯并[a]芘和二苯并[def,p]屈)的类似加合物。结果表明,这种差异是相应芳基硼酸竞争性水解脱硼反应难易程度不同的结果。